News and Trends 4 Jan 2018
Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech
Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of its venture fund to €250M, which will allow it to expand its focus. Boehringer Ingelheim is a big pharma hoping to drive the development of new and effective medicines. Today, the company announced that it has more than doubled the size of […]